BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15375789)

  • 1. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
    Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
    Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.
    Tanabe K; Liu Z; Patel S; Doble BW; Li L; Cras-Méneur C; Martinez SC; Welling CM; White MF; Bernal-Mizrachi E; Woodgett JR; Permutt MA
    PLoS Biol; 2008 Feb; 6(2):e37. PubMed ID: 18288891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
    Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
    Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of dishevelled and beta-catenin in rat skeletal muscle: an alternative exercise-induced GSK-3beta signaling pathway.
    Aschenbach WG; Ho RC; Sakamoto K; Fujii N; Li Y; Kim YB; Hirshman MF; Goodyear LJ
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E152-8. PubMed ID: 16478782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
    Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
    Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
    Henriksen EJ; Teachey MK
    Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression.
    Cleasby ME; Reinten TA; Cooney GJ; James DE; Kraegen EW
    Mol Endocrinol; 2007 Jan; 21(1):215-28. PubMed ID: 17021050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance.
    Murata Y; Tsuruzoe K; Kawashima J; Furukawa N; Kondo T; Motoshima H; Igata M; Taketa K; Sasaki K; Kishikawa H; Kahn CR; Toyonaga T; Araki E
    Biochem Biophys Res Commun; 2007 Dec; 364(2):301-7. PubMed ID: 17950694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice.
    Liu Y; Tanabe K; Baronnier D; Patel S; Woodgett J; Cras-Méneur C; Permutt MA
    Diabetologia; 2010 Dec; 53(12):2600-10. PubMed ID: 20821187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.
    Liu Z; Wu Y; Nicklas EW; Jahn LA; Price WJ; Barrett EJ
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E523-8. PubMed ID: 14656717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalin attenuates high fat diet-induced insulin resistance and ectopic fat storage in skeletal muscle, through modulating the protein kinase B/Glycogen synthase kinase 3 beta pathway.
    Xi YL; Li HX; Chen C; Liu YQ; Lv HM; Dong SQ; Luo EF; Gu MB; Liu H
    Chin J Nat Med; 2016 Jan; 14(1):48-55. PubMed ID: 26850346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.
    Ciaraldi TP; Carter L; Mudaliar S; Henry RR
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):153-8. PubMed ID: 19505532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
    Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.
    Moller DE; Chang PY; Yaspelkis BB; Flier JS; Wallberg-Henriksson H; Ivy JL
    Endocrinology; 1996 Jun; 137(6):2397-405. PubMed ID: 8641192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Porphyromonas gingivalis translocates to the liver and regulates hepatic glycogen synthesis through the Akt/GSK-3β signaling pathway.
    Ishikawa M; Yoshida K; Okamura H; Ochiai K; Takamura H; Fujiwara N; Ozaki K
    Biochim Biophys Acta; 2013 Dec; 1832(12):2035-43. PubMed ID: 23899607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.
    MacAulay K; Doble BW; Patel S; Hansotia T; Sinclair EM; Drucker DJ; Nagy A; Woodgett JR
    Cell Metab; 2007 Oct; 6(4):329-37. PubMed ID: 17908561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Carter L; Johnson K; Henry RR
    Diabetes; 2002 Jul; 51(7):2190-8. PubMed ID: 12086949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucosylated chondroitin sulfate from sea cucumber in combination with rosiglitazone improved glucose metabolism in the liver of the insulin-resistant mice.
    Hu S; Chang Y; Wang J; Xue C; Li Z; Wang Y
    Biosci Biotechnol Biochem; 2013; 77(11):2263-8. PubMed ID: 24200792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes.
    Henriksen EJ
    Curr Diabetes Rev; 2010 Sep; 6(5):285-93. PubMed ID: 20594161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.